Matches in Wikidata for { <http://www.wikidata.org/entity/Q66387320> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q66387320 description "clinical trial" @default.
- Q66387320 description "ensayu clínicu" @default.
- Q66387320 description "klinisch onderzoek" @default.
- Q66387320 description "клінічне випробування" @default.
- Q66387320 name "Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction" @default.
- Q66387320 name "Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction" @default.
- Q66387320 type Item @default.
- Q66387320 label "Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction" @default.
- Q66387320 label "Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction" @default.
- Q66387320 prefLabel "Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction" @default.
- Q66387320 prefLabel "Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction" @default.
- Q66387320 P1050 Q66387320-C02AEE7F-1601-4B13-B810-C6703624C06E @default.
- Q66387320 P1132 Q66387320-EAF99B25-4159-42D2-B007-BB5C5F6034B9 @default.
- Q66387320 P1476 Q66387320-140D95D8-0CFE-42B9-9D2B-322DA2ADFC2A @default.
- Q66387320 P17 Q66387320-67533B9B-2A1D-4872-89A2-DA8AA4DBC0FF @default.
- Q66387320 P2899 Q66387320-42DE31CB-9C04-4723-8DD5-1F6304C9F3F6 @default.
- Q66387320 P3098 Q66387320-FEB35916-1ADC-4C1B-9241-88ED13D59ED1 @default.
- Q66387320 P31 Q66387320-7A713049-B1F7-4BBF-849E-1693A4317E9D @default.
- Q66387320 P4135 Q66387320-EFB95AD0-DFA9-4245-BABD-D5F3964F7A38 @default.
- Q66387320 P4844 Q66387320-2D67AA85-85E0-425E-9591-560D69535C9C @default.
- Q66387320 P580 Q66387320-C68CB02F-8920-4F81-8C23-2C50A76F354A @default.
- Q66387320 P582 Q66387320-0379D155-416E-4AA4-A2A1-8B8F2E27A47D @default.
- Q66387320 P6099 Q66387320-9DBFB91D-7E0D-4040-A350-E2E23EE5854A @default.
- Q66387320 P8363 Q66387320-EBE92529-9E0D-426B-974A-21B8D392281A @default.
- Q66387320 P1050 Q29496 @default.
- Q66387320 P1132 "+37" @default.
- Q66387320 P1476 "Open-Label Phase 2 Trial of Vyxeos in Patients With Intermediate and High-Risk Acute Myeloid Leukemia Who Have Failed an Initial Cycle of Standard Cytarabine and Daunorubicin Chemotherapy" @default.
- Q66387320 P17 Q30 @default.
- Q66387320 P2899 "+18" @default.
- Q66387320 P3098 "NCT04049539" @default.
- Q66387320 P31 Q30612 @default.
- Q66387320 P4135 "+75" @default.
- Q66387320 P4844 Q180983 @default.
- Q66387320 P580 "2019-10-31T00:00:00Z" @default.
- Q66387320 P582 "2021-12-31T00:00:00Z" @default.
- Q66387320 P6099 Q42824440 @default.
- Q66387320 P8363 Q78089383 @default.